The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Tumors and inflammatory infiltrates: Friends or foes?
Abstract
The recognition of a role for inflammation in the natural history of a tumor has a long record, stretching from the mid-19th century. From the times of Virkow, who postulated that cancer originates from inflamed tissues, to Metchnikoff and many others, this field has continued to excite (and divide) the scientific community. The question as to whether the inflammatory infiltrate helps or hinders tumors is still open. In a sense, modern molecular biology has, if anything, worsened this dualism, and the literature on this issue shows a plethora of conflicting reports. We would like to provide another contribution to this topic, which was the subject of a recent brilliant review (Balkwill F and Mantovani A. Lancet 2001; 357: 539-45), by focussing more specifically to the relation between inflammation and tumor invasion and how this could drive rational therapeutic approaches.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TAMs have a dual role in neoplasms — although they may kill neoplastic cells following activation by IL-2, interferon and IL-12 (refs 15, 16), TAMs produce a number of potent angiogenic and lymphangiogenic growth factors, cytokines and proteases, all of which are mediators that potentiate neoplastic progression17.”
From Inflammation and cancer (2002) · cites this paper as [15]
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 1×
“ATP synthase-inhibitors, such as Piceatannol [67] and Resveratrol [68] are effective inhibitors of tumor growth.”
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,232
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909.909_909_928 · Cited by 2,126
Ulcerative Colitis and Colorectal Cancer
Ekbom, A., Helmick, C. G., Zack, M. M., & Adami, H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,794
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,547
Flagged first, then by citations
1 of the 125 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Rollins BJ. Chemokines. Blood 1997; 90: 909–28. · DOI
- Richard D, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000; 275: 26765–71. · DOI
- Johnson W, Anderson K, Lazovich D et al. Association of aspirin and other NSAID use with incidence of postmenopausal breast cancer. In Proceedings of AACR, New Orleans 2001; 763.
- Cao Y, Prescott S. Fatty acid CoA-ligase 4 and cyclooxygenase 2 promote carcinogenesis by lowering the intracellular level of free arachidonic acid. In Proceedings of AACR, New Orleans 2001; 591.
Cited by
Sorted by citations
Items 101–200 of 230
Douglas, W. G., Tracy, E., Tan, D., Yu, J., Hicks, W. L., Rigual, N., Loree, T. R., Wang, Y., & Baumann, H. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.585.2.10 · Cited by 44
Host Cxcr2-dependent regulation of mammary tumor growth and metastasis
Sharma, B., Nannuru, K. C., Varney, M. L., & Singh, R. K. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9691-0 · Cited by 45
Joimel, U., Gest, C., Soria, J., Pritchard, L.-L., Alexandre, J., Laurent, M., Blot, E., Cazin, L., Vannier, J., Varin, R., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-375 · Cited by 44
Schietroma, M., Romano, L., Schiavi, D., Pessia, B., Mattei, A., Fiasca, F., Carlei, F., & Giuliani, A. (2022) · Surgical Oncology · doi:10.1016/j.suronc.2022.101791 · Cited by 42
Fu, Y., Liu, W. W., Ouyang, D., Yang, A., & Zhang, Q. (2016) · Medicine · doi:10.1097/md.0000000000002689 · Cited by 42
Zhang, X., Qin, X., Qin, C. Y., Yin, Y., Chen, Y., & Zhu, H. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1361-y · Cited by 42
Yeo, M., Park, H.-K., Lee, K.-M., Lee, K. J., Kim, J., Cho, S. W., & Hahm, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.214 · Cited by 42
Melanoma and innate immunity – Active inflammation or just erroneous attraction?
Navarini, A. A., & Conrad, C. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.10.012 · Cited by 41
Chakraborty, P., Chatterjee, S., Ganguly, A., Saha, P., Adhikary, A., Das, T., Chatterjee, M., & Choudhuri, S. K. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0611287 · Cited by 41
Wehler, T. C., Graf, C., Biesterfeld, S., Brenner, W., Schadt, J., Gockel, I., Berger, M. R., Thüroff, J. W., Galle, P. R., Moehler, M. H., et al. (2008) · Journal of Oncology · doi:10.1155/2008/626340 · Cited by 40
Yui, S., Osawa, Y., Ichisugi, T., & Morimoto‐Kamata, R. (2014) · Mediators of Inflammation · doi:10.1155/2014/971409 · Cited by 38
Talesh, G. A., Ebrahimi, Z., Badiee, A., Mansourian, M., Attar, H., Arabi, L., Jalali, S. A., & Jaafari, M. R. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.05.016 · Cited by 39
The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers
Midavaine, É., Côté, J., & Sarret, P. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09974-2 · Cited by 39
Progressive cellular response in the lamina propria of the colorectal adenoma–carcinoma sequence
Cui, G., Yuan, A., Vonen, B., & Florholmen, J. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03273.x · Cited by 37
Kaur, J., & Sanyal, S. N. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0441-6 · Cited by 36
Solar cheilosis: An ominous precursor
Jadotte, Y. T., & Schwartz, R. A. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.09.039 · Cited by 36
Inflammation, HIF-1, and the Epigenetics That Follows
Brigati, C., Banelli, B., Vinci, A. D., Casciano, I., Allemanni, G., Forlani, A., Borzì, L., & Romani, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/263914 · Cited by 36
Self-citationEl-Badawy, A., Ghoneim, M. A., Gabr, M. M., Salah, R. A., Mohamed, I. K., Amer, M., & El‐Badri, N. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0709-9 · Cited by 34
Yui, S., Tomita, K., Kudo, T., Ando, S., & Yamazaki, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00097.x · Cited by 34
Cui, G., Yuan, A., Goll, R., Olsen, T., Husebekk, A., Vonen, B., & Florholmen, J. R. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0345-9 · Cited by 34
Lv, Z., Wei, Z., Zhang, Z., Li, C., Shao, Y., Zhang, W., Zhao, X., Li, Y., Duan, X., & Xiong, J. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.07.024 · Cited by 33
The Central Role of Inflammation Associated with Checkpoint Inhibitor Treatments
Vâjâitu, C., DRAGHICI, C. C., Solomon, I., Lisievici, C. V., Popa, A. V., Lupu, M., Căruntu, C., Constantin, M. M., & Voiculescu, V. M. (2018) · Journal of Immunology Research · doi:10.1155/2018/4625472 · Cited by 32
Zimmermann, T., Moehler, M. H., Gockel, I., Sgourakis, G. G., Biesterfeld, S., Müller, M., Berger, M. R., Lang, H., Galle, P. R., & Schimanski, C. C. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0868-y · Cited by 32
Lymphangiogenesis, inflammation and metastasis.
SCHOPPMANN, S. F. (2005) · PubMed · Cited by 32
Cui, G., Yang, H., Zhao, J., Yuan, A., & Florholmen, J. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-014-9799-1 · Cited by 31
Morimoto‐Kamata, R., Mizoguchi, S.-I., Ichisugi, T., & Yui, S. (2012) · Mediators of Inflammation · doi:10.1155/2012/456462 · Cited by 31
Aparicio, L. M. A., Fernandez, I. P., & Cassinello, J. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1657-7 · Cited by 30
González, L. O., González‐Reyes, S., Marín, L., González-Llorente, L., González, J. M., Lamelas, M. L., Merino, A., Rodríguez, E., Pidal, I., del Casar, J. M., et al. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03723.x · Cited by 30
Kamoshida, G., Matsuda, A., Sekine, W., Mizuno, H., Oku, T., Itoh, S., Irimura, T., & Tsuji, T. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.029 · Cited by 29
Hu, X., Tian, T., Sun, Q., & Jiang, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.945820 · Cited by 27
Low, H. B., Png, C. W., Li, C., Wang, D. Y., Wong, S. B. J., & Zhang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10980 · Cited by 27
Arora, S., Khan, S. F., Zaki, A., Tabassum, G., Mohsin, M., Bhutto, H. N., Ahmad, T., Fatma, T., & Syed, M. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.002 · Cited by 26
Schanoski, A. S., Jurado, T., Córdoba, R., Siliceo, M., del Fresno, C., Goméz-Piña, V., Toledano, V., Vallejo‐Cremades, M. T., Alfonso-Iñiguez, S., Carballo-Palos, A., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.124 · Cited by 26
Hepatitis B virus X protein in liver tumor microenvironment
Fu, S., Zhou, R., Li, N., Huang, Y., & Fan, X. (2016) · Tumor Biology · doi:10.1007/s13277-016-5406-2 · Cited by 26
Targeting macrophage anti-tumor activity to suppress melanoma progression
Wang, H., Yang, L., Yang, L., Liu, C., Zhang, L., & Zhang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.14474 · Cited by 26
The Complex Role of Thrombin in Cancer and Metastasis: Focus on Interactions with the Immune System
Aleksandrowicz, K., Hempel, D., Polityńska, B., Wojtukiewicz, A. M., Honn, K. V., Tang, D. G., & Wojtukiewicz, M. Z. (2023) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0043-1776875 · Cited by 26
Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer
Kumar, J., Murugaiah, V., Sotiriadis, G., Kaur, A., Jeyaneethi, J., Sturniolo, I., Alhamlan, F. S., Chatterjee, J., Hall, M., Kishore, U., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00542 · Cited by 25
Cheung, N. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.9.1241 · Cited by 25
Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas
Liu, J., Lu, G., Fuai, T., Liu, Y., & Cui, G. (2009) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-009-0846-3 · Cited by 24
Masemann, D., Meissner, R., Schied, T., Lichty, B. D., Rapp, U. R., Wixler, V., & Ludwig, S. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1885778 · Cited by 22
SERUM CYTOKINE OF IL-2, IL-10 AND IL-12 LEVELS IN PATIENTS WITH STOMACH ADENOCARCINOMA
Shokrzadeh, M., Mohammadpour, A., Hoseini, V., Abediankenari, S., Ghassemi-Barghi, N., & Tabari, Y. S. (2018) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.201800000-83 · Cited by 23
Yokoi, K., Hawke, D. H., Oborn, C. J., Jang, J., Nishioka, Y., Fan, D., Kim, S. W., Kim, S.-J., & Fidler, I. J. (2011) · Translational Oncology · doi:10.1593/tlo.10202 · Cited by 22
Kamoshida, G., Matsuda, A., Miura, R., Takashima, Y., Katsura, A., & Tsuji, T. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9536-7 · Cited by 22
GRP78 plays an integral role in tumor cell inflammation-related migration induced by M2 macrophages
Zhang, L., Li, Z., Ding, G., La, X., Yang, P., & Li, Z. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.06.008 · Cited by 22
Endoplasmic reticulum stress—A double edged sword for Z alpha-1 antitrypsin deficiency hepatoxicity
Lawless, M. W., Mankan, A. K., Gray, S. G., & Norris, S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.008 · Cited by 22
Interactions between platelets and the cancer immune microenvironment
Tuerhong, N., Yang, Y., Wang, C., Huang, P., & Li, Q. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104380 · Cited by 21
Neutrophil‐to‐lymphocyte and hypopharyngeal cancer prognosis: System review and meta‐analysis
Hu, X., Tian, T., Zhang, X., Sun, Q., Chen, Y., & Jiang, W. (2022) · Head & Neck · doi:10.1002/hed.27246 · Cited by 22
Effects of the Tumor Microenvironment on the Efficacy of Tumor Immunotherapy
Neeson, P. J., & Paterson, Y. Y. W. (2006) · Immunological Investigations · doi:10.1080/08820130600755009 · Cited by 22
Lee, C. J., Hsu, L., Yue, C.-H., Lin, H., Chiu, Y.-W., Lin, Y.-Y., Huang, C., Hung, M., & Liu, J.-Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11337 · Cited by 19
Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing
Zins, K., & Abraham, D. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0290-4_17 · Cited by 21
Cai, C., Wang, L. ‐., Dong, Q., Wu, Z., Li, M. ‐., & Sun, Y. ‐. (2013) · Tissue Antigens · doi:10.1111/tan.12170 · Cited by 17
Therapeutic targeting of tumor-associated macrophages
Rasmussen, R. K., & Etzerodt, A. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.03.002 · Cited by 16
Tomás, T. C., Eiriz, I., Vitorino, M. M., Vicente, R. S., Gramaça, J., Oliveira, A. G., Luz, P., Baleiras, M. M., Spencer, A. S., da Costa, L. L., et al. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i7.1307 · Cited by 18
Microenvironment-Centred Dynamics in Aggressive B-Cell Lymphomas
Cacciatore, M., Guarnotta, C., Calvaruso, M., Sangaletti, S., Florena, A. M., Franco, V., Colombo, M. P., & Tripodo, C. (2012) · Advances in Hematology · doi:10.1155/2012/138079 · Cited by 19
Cho, H. R., Choi, S. H., Lee, N., Hyeon, T., Kim, H., & Moon, W. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029575 · Cited by 18
Araki, T., Tateishi, K., Komatsu, M., Sonehara, K., Wasamoto, S., Koyama, S., Yoshiike, F., Hama, M., Nishie, K., Kondo, D., et al. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14484 · Cited by 13
Jayasinghe, C., Simiantonaki, N., Habedank, S., & Kirkpatrick, C. J. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0162-5 · Cited by 14
Xu, Y., Xu, Z., Li, Q., Guo, L., Wang, Y., Zhou, J., Wang, G., & Liu, Y. (2019) · Journal of Immunology Research · doi:10.1155/2019/7478538 · Cited by 14
Sun, P., Antwi, S. O., Sartorius, K., Zheng, X., & Li, X. (2022) · Cancers · doi:10.3390/cancers14194888 · Cited by 14
SDF1β expression in renal cell carcinoma correlates with grading and infiltration by CD8+ T-cells.
Wehler, T. C., Graf, C., Altherr, K., Zimmermann, T., Brenner, W., Thüroff, J. W., Biesterfeld, S., Gockel, I., Theobald, M., Galle, P. R., et al. (2011) · PubMed · Cited by 14
Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells
Szabo, K. A., & Singh, G. (2005) · Breast Cancer Research · doi:10.1186/bcr1261 · Cited by 14
Peek, E. M., Wang, S., Zhang, H., Huang, J., & Chin, A. I. (2015) · The Prostate · doi:10.1002/pros.22932 · Cited by 13
Cancer modelling in the NGS era – Part I: Emerging technology and initial modelling
Rovigatti, U. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.05.017 · Cited by 13
IgE Interacts with Potent Effector Cells Against Tumors: ADCC and ADCP
Karagiannis, S. N., Nestle, F. O., & Gould, H. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-451-7_8 · Cited by 12
Role of Inflammation in Oral Squamous Cell Carcinoma
Bekta-Kayhan, K. (2012) · InTech eBooks · doi:10.5772/26170 · Cited by 12
A pilot study on acute inflammation and cancer: a new balance between IFN-γ and TGF-β in melanoma
Ma, Y., Sun, T., Liu, Y., Zhao, N., Gu, Q., Zhang, D., Qie, S., Ni, C., Liu, Y., & Sun, B. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-23 · Cited by 12
How lactate affects immune strategies in lymphoma
Zhou, Y., Lou, J., Yuqin, T., Ding, J., Wang, X., & Tang, B. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1480884 · Cited by 11
Lacy, K. E., Karagiannis, S. N., & Nestle, F. O. (2012) · Expert Review of Dermatology · doi:10.1586/edm.11.80 · Cited by 10
Ben‐Baruch, A. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_11 · Cited by 9
Huang, J., Yang, S., Wu, P., Wang, C., Tang, C., & Wang, P.-H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168754 · Cited by 8
Schimanski, C. C., Moehler, M. H., Gockel, I., Zimmermann, T., Lang, H., Galle, P. R., & Berger, M. R. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-0980-6 · Cited by 8
The Role of Th2-Mediated Anti-Tumor Immunity in Tumor Surveillance and Clearance
Simson, L., Ellyard, J. I., & Parish, C. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-451-7_11 · Cited by 8
Nagai, T., Naiki, T., Sugiyama, Y., Etani, T., Aoki, M., Gonda, M., Morikawa, T., Iida, K., Tomiyama, N., Ando, R., et al. (2023) · Translational Andrology and Urology · doi:10.21037/tau-22-805 · Cited by 6
Ye, L.-F., Huang, J., Zhang, L.-P., & Chen, Z. (2015) · The Journal of Laryngology & Otology · doi:10.1017/s0022215115002108 · Cited by 7
Nannuru, K. C., Singh, S., & Singh, R. K. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_27 · Cited by 7
Prognostic Utility of Pretreatment Neutrophil-Lymphocyte Ratio in Advanced Larynx Cancer
Kotha, N. V., Voora, R. S., Qian, A. S., Kumar, A., Qiao, E. M., Stewart, T. F., Rose, B. S., & Orosco, R. K. (2021) · Biomarker Insights · doi:10.1177/11772719211049848 · Cited by 6
Noonan, D. M., Pennesi, G., & Albini, A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_10 · Cited by 6
Self-citationRöhl, L., Wellhausen, J., Berszin, M., Krücken, I., Zebralla, V., Pirlich, M., Wiegand, S., Dietz, A., Wald, T., & Wichmann, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1237623 · Cited by 5
Bujanda, Z. A. L., Hadavi, S. H., de Porras, V. R., Martinez‐Balibrea, E., & Dallos, M. C. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.03.008 · Cited by 5
The Role of Inflammasomes in Chronic Oral Inflammatory Disease and Oral Cancer: A Narrative Review
Al‐Natour, B., Rasheed, I. B., & Karim, I. A. E. (2025) · Dentistry Journal · doi:10.3390/dj13120609 · Cited by 4
Inflammation as a Target in Prostate Cancer
Lucia, M. S., Lambert, J. R., Platz, E. A., & Marzo, A. M. D. (2010) · Springer eBooks · doi:10.1007/978-1-60327-829-4_33 · Cited by 4
Macrophage cytotoxic activity and its role in the tumor pathogenesis
Kovaleva, O. V., Алексеевна, П. П., & Gratchev, A. N. (2022) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2022-50-008 · Cited by 5
Membrane phospholipid asymmetry: biochemical and pathophysiological perspectives
Bevers, E. M., Comfurius, P., & Zwaal, R. F. A. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)33019-x · Cited by 4
Urinary Neopterin Levels in Patients with Thyroid Cancer
İnançlı, S. S., Caner, S., Balkan, F., Tam, A. A., Güler, G., Ersoy, R., & Çakır, B. (2014) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-014-0710-x · Cited by 4
Mestrado Integrado em Medicina Veterinária
Veterinárias, C. A. E. (2011) · Cited by 3
Cancer as a chronic inflammatory disease: role of immunotherapy
Lotze, M. T., & Herberman, R. B. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7861-6_2 · Cited by 3
Models of inflammatory processes in cancer
Benelli, R., Frumento, G., Albini, A., & Noonan, D. M. (2006) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7520-1_4 · Cited by 3
Self-citationInflammation, necrosis, and cancer
Lotze, M. T. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7861-6_9 · Cited by 3
Molecular and Biological Characteristics of Stroma and Tumor Cells in Colorectal Cancer
Gao, J. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 3
Tan, Z., Zhang, Q., Wang, Y., Wang, Y., Zhang, S., Xing, X., Liu, H., Shen, Z., & Sang, W. (2024) · Annals of Hematology · doi:10.1007/s00277-024-05852-3 · Cited by 2
Xiao, W., Yu, K., Deng, X., & Zeng, Y. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156726 · Cited by 2
Role and Redirection of IgE against Cancer
Nigro, E. A., Siccardi, A. G., & Vangelista, L. (2013) · Antibodies · doi:10.3390/antib2020371 · Cited by 2
Irshad, K., Madan, E., & Chosdol, K. (2016) · Springer eBooks · doi:10.1007/978-981-10-1711-7_10 · Cited by 2
Tumor associated macrophages: current research and perspectives of clinical use
Gratchev, A. N., Samoilova, D. V., Рашидова, М. А., Petrenko, A. A., & Kovaleva, O. V. (2019) · Advances in molecular oncology · doi:10.17650/2313-805x-2018-5-4-20-28 · Cited by 4
The Angiogenic Switch: Role of Immune Cells
Noonan, D. M., Ventura, A., Bruno, A., Pagani, A., & Albini, A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7219-4_5 · Cited by 2
Self-citationScar Carcinoma (Marjolin Ulcer) and Bullous Disease
Satter, E. K., Schaffer, J. W., Andea, A. A., & Metcalf, J. S. (2005) · Pathology Case Reviews · doi:10.1097/01.pcr.0000185518.24928.0f · Cited by 2
Hlávková, D., Kopecký, O., Lukešová, Š., Vroblova, V., Andrýs, C., Morávek, P., Podhola, M., Vokurková, D., & Šafránek, H. (2008) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2017.22 · Cited by 2
Liu, H., Wang, J., Zhang, W., Zhao, X., & Jin, H. (2025) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2025.105346 · Cited by 1
Cancer-Associated Fibroblasts and the Role of TGF-β
Micke, P., Moustakas, A., Ohshima, M., & Kappert, K. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_27 · Cited by 1
Modeling Breast Cancer Progression in 4-D
Sameni, M., Mullins, S., Moin, K., Sloane, B. F., & Osuala, K. O. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5647-6_10 · Cited by 1
Metadata
- Authors
- Brigati, C., Noonan, D. M., Albini, A., & Benelli, R.
- Corresponding author
- Brigati, Claudio
- Venue
- Clinical & Experimental Metastasis
- Published
- 2002-05
- Volume
- 19
- Issue
- 3
- Pages
- 247-258
- ISSN
- 0262-0898 (ISSN-L)
- 1573-7276
- OpenAlex
- W1550108534
- Cited by
- 230
- References
- 125
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 3 · 2022: 9 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 10 · 2016: 10 · 2015: 11 · 2014: 6 · 2013: 10 · 2012: 19
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Clinical & Experimental Metastasis (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Funders
- Compagnia di San Paolo
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- tumor inflammation, inflammatory cell infiltration, tumor invasion, tumor microenvironment
- MeSH terms
- Humans, Inflammation, Models, Biological, Neoplasms, Prostaglandin-Endoperoxide Synthases, Transcription Factors, Cytokines, Receptors, Cytoplasmic and Nuclear, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review